Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Xenon Pharmaceuticals Inc...

    NASDAQ: XENE · Real-Time Price · USD
    31.64
    0.91 (2.96%)
    At close: Jun 06, 2025, 3:59 PM
    31.64
    0.00%
    After-hours: Jun 06, 2025, 04:40 PM EDT

    Xenon Pharmaceuticals Statistics

    Share Statistics

    Xenon Pharmaceuticals has 76.73M shares outstanding. The number of shares has increased by 1.42% in one year.

    Shares Outstanding

    n/a
    		 76.73M

    Shares Change (YoY)

    n/a
    		 1.42%

    Shares Change (QoQ)

    n/a
    		 0.4%

    Owned by Institutions (%)

    n/a
    		 97.9%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 64

    FTD / Avg. Volume

    n/a
    		 0.01%

    Short Selling Information

    The latest short interest is 3.47M, so 4.52% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 3.47M

    Short % of Shares Out

    n/a
    		 4.52%

    Short % of Float

    n/a
    		 5.05%

    Short Ratio (days to cover)

    n/a
    		 2.12

    Valuation Ratios

    The PE ratio is -13.03 and the forward PE ratio is -6.94. Xenon Pharmaceuticals's PEG ratio is -1.27.

    PE Ratio

    n/a
    		 -13.03

    Forward PE

    n/a
    		 -6.94

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 3.3

    PB Ratio

    n/a
    		 4.04

    P/FCF Ratio

    n/a
    		 -16.55

    PEG Ratio

    n/a
    		 -1.27
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Xenon Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 17.85, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 17.85

    Quick Ratio

    n/a
    		 17.85

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 -0.04

    Debt / FCF

    n/a
    		 -0.05

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-741,550.63

    Employee Count

    n/a
    		 316

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -4.09M

    Effective Tax Rate

    n/a
    		 1.72%

    Stock Price Statistics

    The stock price has increased by -18.77% in the last 52 weeks. The beta is 1.1, so Xenon Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.1

    52-Week Price Change

    n/a
    		 -18.77%

    50-Day Moving Average

    n/a
    		 32.95

    200-Day Moving Average

    n/a
    		 38.12

    Relative Strength Index (RSI)

    n/a
    		 45.24

    Average Volume (20 Days)

    n/a
    		 974,969

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -279.3M

    Net Income

    n/a
    		 -234.33M

    EBITDA

    n/a
    		 -235.86M

    EBIT

    n/a
    		 -238.42M

    Earnings Per Share (EPS)

    n/a
    		 -3.01
    Full Income Statement

    Balance Sheet

    The company has 142.71M in cash and 9.02M in debt, giving a net cash position of 133.7M.

    Cash & Cash Equivalents

    n/a
    		 142.71M

    Total Debt

    n/a
    		 9.02M

    Net Cash

    n/a
    		 133.7M

    Retained Earnings

    n/a
    		 -899.47M

    Total Assets

    n/a
    		 743.28M

    Working Capital

    n/a
    		 549.6M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -181.39M and capital expenditures -3.08M, giving a free cash flow of -184.46M.

    Operating Cash Flow

    n/a
    		 -181.39M

    Capital Expenditures

    n/a
    		 -3.08M

    Free Cash Flow

    n/a
    		 -184.46M

    FCF Per Share

    n/a
    		 -2.37
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    XENE does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for XENE is $53, which is 72.5% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $53

    Price Target Difference

    n/a
    		 72.5%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 11
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 31.78

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist